WHC is still in active development. Read this to understand our approach.
depiction of VIROVYVQCGLCII-UHFFFAOYSA-N.svg
tripsit

amobarbital

Check on tripsit

psychonaut

Amobarbital

Check on psychonaut

isomerdesign

Amobarbital

Check on isomerdesign

pubchem

Amobarbital

Check on pubchem

drugmap

Amobarbital

Check on drugmap

wiki

Amobarbital

Check on wiki

Data

InChI: InChI=1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)

Synonyms: Eunoctal,component of Q-Caps,5-Ethyl-5-isopentylbarbituric acid,5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione, Component of Q-Caps,CBDivE_006514,AMOBARBITAL [INN],Amobarbital [USP:INN:BAN:JAN], Amital,Amobarbital 1.0 mg/ml in Methanol,Dorlotyn, Isoamylethylbarbituric acid,5-Ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione,5-Ethyl-5-isoamylbarbituric acid,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-,AMOBARBITAL [JAN],Dormytal,Barbituric acid, 5-ethyl-5-isoamyl-,Sumital,NSC-10815,5-ethyl-5-(3-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione,component of Dexamyl (Salt/Mix),DTXSID9020081,Amylbarbitone,5-Ethyl-5-isopentyl-2,4,6(1H,3H,5H)-pyrimidinetrione #, Talamo, Amobarbitalum,5-Ethyl-5-(3-methylbutyl)-2,6(1H,3H,5H)-pyrimidinetrione,KBio1_000994,CCRIS 5454,DSSTox_CID_81, Pentymal,AMOBARBITAL [VANDF],NSC 10815,Amobarbitalum,DSSTox_GSID_20081,component of Dexamyl,Amylobarbitone,IDI1_000994,WLN: T6VMVMV FHJ F2 F2Y1&1,Amobarbitalum [INN-Latin], Ethylisopentylbarbituric acid, 5-Ethyl-5-isoamylmalonyl urea, 5-Ethyl-5-isopentylbarbituric acid,Stadadorm,DivK1c_000994,SCHEMBL15364946, Amybal, Amasust, Amobarbitalum [INN-Latin],Barbituric acid, 5-ethyl-5-isopentyl-,HSDB 3286, Component of Dexamyl, Stadadorm,Amasust,VIROVYVQCGLCII-UHFFFAOYSA-,CHEBI:2673, 5-Ethyl-5-(3-methylbutyl)barbituric acid,AMOBARBITAL [WHO-DD],component of 15-90 (Salt/Mix), Dormytal,NINDS_000994,Amobarbital 0.1 mg/ml in Methanol, Amobarbitale,DSSTox_RID_75353,Tox21_112866, Isomytal,5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione, Amylbarbitone, Sumital,AMAL, Sednotic,Mylodorm,UNII-GWH6IJ239E,5-Ethyl-5-isoamylmalonyl urea,Somnal,Sednotic,Amobarbital, Somnal, Isomyl, Mylodorm,Barbamil, Schiwanox,2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-, 5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione, Amylobarbital,GWH6IJ239E,Dexamyl (Salt/Mix),NSC32406, Amobarbitone,NSC10815,Amobarbitale [DCIT], Amobarbital suppository dosage form,C07536,5-Ethyl-5-isopentylbarbitursaeure, Amytal, Robarb,Isoamylethylbarbituric acid, Barbamyl,Amobarbital (JP17/INN),57-43-2, Amobarbital [INN:JAN],Amybal,Isomytal (TN),SCHEMBL43780, 5-ethyl-5-(3-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione,amobarbital,Barbamyl, Binoctal, Amobarbital (JP15/INN),Talamo,Amytal,D00555,NCGC00247711-01, Barbamyl acid,AMOBARBITAL [MI],Schiwanox, 5-Ethyl-5-isopentylbarbitursaeure,Isomytal,component of Q-Caps (Salt/Mix),Oprea1_587446,Amobarbitale, Amylobarbitone,DEA No. 2125, 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,5-Ethyl-5-(3-methylbutyl)barbituric acid,component of 15-90, Isomytal (TN),BIDD:PXR0091,5-Isoamyl-5-ethylbarbituric acid,057A558, Amospan,DB01351,NSC-120800,AMOBARBITAL [HSDB],Isomyl,Amospan,NSC120800, Component of 15-90,Binoctal,AMOBARBITAL CII [USP-RS],Barbamyl acid,EINECS 200-330-7,Q415850, 5-Isoamyl-5-ethylbarbituric acid,Pentymalum,AMOBARBITAL [EP IMPURITY],NSC-32406,Ethylisopentylbarbituric acid, Component of Amo-Dextrosule,Amobarbital cii,AMOBARBITAL [MART.],Amobarbitone,Pentymal, Amobarbitale [DCIT],Amobarbital solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,CAS-57-43-2, Barbamil, Dorlotyn, Eunoctal,Amital,component of Amo-Dextrosule,Robarb,ZINC4811698,CHEMBL267894,component of Amo-Dextrosule (Salt/Mix),Amylobarbital, Pentymalum

Estimated data

Solubility: -2.065 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 38.1% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.